How much does Myqorzo (Aficamten Tablets) Cost& price without insurance in China?
Myqorzo® is the commercial brand name of Aficamten Tablets, an orally selective cardiac myosin inhibitor developed by Cytokinetics and marketed by Sanofi. It reduces excessive myocardial contraction by inhibiting cardiac myosin ATPase activity, relieving cardiac hypertrophy of obstructive hypertrophic cardiomyopathy.
Main Indications
Treatment for adult patients with NYHA class II-III obstructive hypertrophic cardiomyopathy to improve exercise tolerance and clinical symptoms.
Common Side Effects
Common mild adverse reactions: Fatigue, diarrhea, dizziness and palpitations.
Laboratory abnormalities: Rare transient liver enzyme fluctuation.
Severe but uncommon risks: Severe bradycardia, heart failure exacerbation and hypersensitivity reactions.
Approval Status in China
Myqorzo® (Aficamten Tablets, 5mg) was officially approved for marketing in China in 2024. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Myqorzo (Aficamten Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
